1Das DK, Sato M, Ray PS, et al. Cardioprotection of red wine:role of polyphenolic antioxidants. Drugs Exptl Clin Res, 1999,25:115-120. 被引量：1
2Pace-Asciak CR, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis;implications for protection against coronary heart disease. Clin Chim Acta,1995,235:207-219. 被引量：1
3Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craninectomy in rats. Stroke ,1989,20:84-91. 被引量：1
4Huang SH, Ming CT, Chun LC, et al. Resveratrol reduction of infarct size in Long-Evens rats subjected to focal cerebral ischemia. Life Sci ,2001,69:1057-1065. 被引量：1
5陈汝兴,郑思榕.破淤通脉散对大鼠脑缺血再灌注损伤的保护作用.医学理论与实践. 1998,11:385-386. Chen RX, Zheng SR. The protection of PoYuTongMai on the reperfusion injury of rat. Medical Theory and Practice, 1998,11:385-386. 被引量：1
7Sun AY, Chen YM. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem Res ,1997,22:1187-1192. 被引量：1
8Karlsson J, Emgard M, Brundin P, et al. Trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. Journal of Neurochemistry, 2000,75:141-150. 被引量：1
9Zini R, Morin C, Bertelli A, et al. Effects of resveratrol on the rat brain respiratory chain. Drugs in Experimental and Clinical Research,1999,25:87-97. 被引量：1
10Nanxin L,Michael K. NF-B the sensor of oxidative stress? FASEB J, 1999, 13:1137-1143. 被引量：1
2Pestka EL, Nash VR. Genetic aspects of migraine headaches. Nurse Pract,2013 ,38(5) :12. 被引量：1
3]Mandard S, Patsouris D. Nuclear controlo[ the inflammatory re sponse in mammals by peroxisome proliferator-activated receptors [J]. PPARRes, 2013, 2013: 613864. 被引量：1
4Tyagi S, Gupta P, Saini AS, et al. The peroxisome proliferator activated receptor] A family of nuclear receptors role in various diseases[J]. J Adv Pharm Technol Res, 2011, 2(4): 236. 被引量：1
5Nardone R, Tezzon F. Short latency trigemino sternoeleidomas toid response in patients with migraine[J]. J Neurol, 2003, 250 (6) ]725. 被引量：1
6Burch R, Wells R. Pathophysiology of migraine[J]. Headache, 2013, 53(2) ]420. 被引量：1
7Wahli W. Peroxisome proliferator-activated receptors (PPARs) : from metabolic control to epidermal wound healing[J]. Swiss Med Wkly, 2002, 132(7 8) :83. 被引量：1
8Akadiri Yessoufou, Walter Wahli. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole or ganism levels[J]. Swiss Med Wkly, 2010, 140: w13071. 被引量：1
9Antoinette Defaux, Marie Gabrielle Zurich, et al. Effects of thePPAR ]3 agonist GW501516 in an in vitro model of brain inflam- mation and antibody-induced demyelination[J]. J Neuroinflam mation, 2009,6: 15. 被引量：1
10Di Paola R, Esposito E, Mazzon E,et al. GW0742, a selective PPAR-beta/delta agonist, contributes to the resolution o{ in- flammation after gut ischemia/reperfusion injury[J]. J Leukoc Biol,2010 ,88(2) ]291. 被引量：1
